Recently, Taikang Insurance Group and Asia's largest and the world's second largest listed medical group IHH Healthcare Group (hereinafter referred to as "IHH") jointly announced that Taikang will invest more than 1 billion yuan in I-HH's PCH Holding, which focuses on developing China's business. Pte. Ltd. (hereinafter referred to as “Baihui Chinaâ€), and reached a comprehensive strategic cooperation with Parkway China shareholders and I-HH wholly-owned subsidiary Parkway Medical Group. The investment is carried out by Taikang's Taikang Assets. The investment will be used to develop Parkway China's hospital and clinic business in China, including the opening of new clinics and hospitals in several key economic circles in China.
Taikang and IHH will carry out strategic cooperation in the field of big health. Both parties will rely on Taikang's huge customer resources, industrial chain resources and China's domestic service network to build China with the brand advantage of I-HH and foreign professional operation experience. The internationalization, clinic and hospital services, which are featured for the domestic middle and high-end customers, enhance the distribution of Parkway China's medical service network in China and provide quality medical services for Chinese patients.
Mushrooms Extract
Our mushrooms extract products are mainly divided into: Shitake Mushroom Extract ; Reishi Mushroom Extract ;Hericium Erinaceus Extract; Chaga Mushroom Extract ; Cordyceps Militaris Extract; Phellinus Linteus Extract ;Tremella Fuciformis Extract; Black Fungus Extract ; Agaricus Blazei Extract ;Antrodia Camphorata Extract; Enoki Mushroom Extract ; Maitake Mushroom Extract ;Coriolus Mushroom Extract.
Mushrooms Extract,Shiitake Mushroom Extract,Fungi Extract,Mushroom Extract Powder
Shaanxi Zhongyi Kangjian Biotechnology Co.,Ltd , https://www.zhongyiherbs.com